SNW.XETRA Sanofi

Healthcare Pharmaceuticals XETRA Stock Exchange
81.87 EUR
Close of Nov 6, 2026
69.77 85.95
Market cap
EUR 98.1B
P/E
23.7x
P/B
1.38x
ROE
9.1%
Dividend yield
4.87%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNW.XETRA undervalued?

Graham number
Price81.87
Graham value67.91
Premium20.6%

SNW.XETRA trades 20.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sanofi fundamental analysis

No fundamental analysis for Sanofi yet.

Sanofi stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu…

Full company profile